Table 3 Perioperative course and outcome: elevated RVSP group versus normal RVSP group

Surgery

Duration of surgery: minutes, (median, IQR)

90 (60,115)

90 (60,120)

0.073

Hemiarthroplasty of femur, no. (%)

37 (88%)

37 (66%)

0.012

Total or revision arthroplasty, no. (%)

4 (9%)

19 (34%)

0.003

Closed reduction of fractured femur, no (%)

1 (2%)

0 (0%)

0.290

Anesthesia

Spinal anesthesia, no. (%)

23 (54%)

31 (55%)

0.922

General anesthesia, no. (%)

19 (45%)

25 (45%)

1.000

Arterial line inserted, no. (%)

29 (67%)

34 (60%)

0.479

Central venous catheter inserted, no. (%)

10 (24%)

10 (18%)

0.469

Vasopressor infusion via CVC, no. (%)

6 (14%)

6 (11%)

0.656

Hemodynamic instability, no. (%)

16 (38%)

14 (25%)

0.169

Outcome

Admitted to a Critical Care bed, no. (%)

6 (14%)

9 (16%)

0.785

Critical Care LOS, days, (median, IQR)

2 (2,4)

3 (3,4)

0.549

Time from surgery to hospital discharge, days (median, IQR)

19 (12, 54)

14 (8, 32)

0.431

Hospital mortality, no. (%)

8 (19%)

0 (0%)

< 0.001

Survival to hospital discharge, no. (%)

34 (81%)

56 (100%)

< 0.001

Time to death after surgery, days, (median IQR)

18 (10,33)

N/A

N/A

Deaths ≤ 7 days after surgery, no. (%)

3 (37%)

N/A

N/A

Deaths ≥ 8 days after surgery, no. (%)

5 (62%)

N/A

N/A

Cause of death: cardiac arrest, no. (%)

3 (37%)

N/A

N/A

Cause of death: pneumonia ± progression of comorbid conditions, no. (%)

5 (62%)

N/A

N/A